AXIM Biotechnologies is an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products as well as alternative sources of energy. We prioritize the well-being of our customers while embracing a solid fiscal strategy. We believe to be setting the green standard for cannabinoid bioscience through the discovery and commercialization of new materials and technologies for healthy living, all while respecting the environment. Stand 20.11.2016
WKN: A2DF26 ISIN: US05463V1008 Kürzel: AXIM (OTC) in
handelbar: NEIN
Gründungsjahr: 2010 Haupthandelsplatz
Vollzogene Namenswechsel Axim International Inc bis 07/2014 echnical Ventures, Inc. bis 05/2010 Land
Angestellte: k.A.